title: Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts.
authors.forename: R
authors.initials: R
authors.lastname: Storb
authors.forename: J E
authors.initials: JE
authors.lastname: Sanders
authors.forename: M
authors.initials: M
authors.lastname: Pepe
authors.forename: C
authors.initials: C
authors.lastname: Anasetti
authors.forename: F R
authors.initials: FR
authors.lastname: Appelbaum
authors.forename: C D
authors.initials: CD
authors.lastname: Buckner
authors.forename: H J
authors.initials: HJ
authors.lastname: Deeg
authors.forename: K
authors.initials: K
authors.lastname: Doney
authors.forename: J
authors.initials: J
authors.lastname: Hansen
authors.forename: P
authors.initials: P
authors.lastname: Martin
mesh_terms: D000741:Anemia, Aplastic / Q000628:therapy*; D016026:Bone Marrow Transplantation; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*
chemical_list: D003524:Cyclosporins; D003520:Cyclophosphamide; D008727:Methotrexate